Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Thorac Oncol. 2010 Oct;5(10):1551–1558. doi: 10.1097/JTO.0b013e3181e9da60

Table 4.

Detection capabilities for the EGFR mutation-specific antibodies.

Sensitivity Specificity Accuracy PPV NPV
E746-A750 81.8% 100% 97.1% 100% 96.7%
All exon 19 mt 50% 100% 87.1% 100% 85.2%
L858R* 75% 96.6% 92.9% 81.8% 94.9%
E746-A750 + L858R 78.3% 95.7% 90% 90% 90%
Any mutation of All Ex19 mt + L858R 43.9% 99.9% 64.3% 90% 54%

PPV=Positive predictive values, NPV=Negative predictive values

*

Including 2573 T>K (K=G or T)